ArticleFrontiers in immunology2018

Treatment Effects of the Second-Generation Tyrosine Kinase Inhibitor Dasatinib on Autoimmune Arthritis.

Kai Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.